A Phase 1, Open-Label, Multicenter Study to Determine the Pharmacokinetics and Safety of Intravenous Eravacycline in Children with Suspected or Confirmed Bacterial Infection

Administered By

Awarded By

Contributors

Start/End

  • March 8, 2019 - March 14, 2020